ATHE Alterity Therapeutics Limited

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-163

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of January 2025

 

Alterity Therapeutics Limited

(Name of Registrant)

 

Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076)

 

 

 

ALTERITY THERAPEUTICS LIMITED

(a development stage enterprise)

 

The following exhibits are submitted:

 

99.1

ATH - Application for quotation of securities

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Alterity Therapeutics Limited
	By:	/s/ Geoffrey P. Kempler
		Geoffrey P. Kempler
		Chairman

 

Date: January 30, 2025

 

 

2

Exhibit 99.1

 

Appendix 2A - Application for quotation of securities

 

Announcement Summary

 

 

Entity name

 

ALTERITY THERAPEUTICS LIMITED

 

Announcement Type

 

New announcement

 

Date of this announcement

 

Thursday January 30, 2025

 

The +securities to be quoted are:

 

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

 

Total number of +securities to be quoted

 

	ASX +security code	Security description	Number of +securities to be quoted	Issue date
	ATH	ORDINARY FULLY PAID	6,333,333	30/01/2025

Refer to next page for full details of the announcement

 

 

Appendix 2A - Application for quotation of securities

 

Part 1 - Entity and announcement details

 

 

1.1 Name of entity

 

ALTERITY THERAPEUTICS LIMITED

 

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

 

	1.2 Registered number type	Registration number
	ABN	37080699065

 

1.3 ASX issuer code

 

ATH

 

1.4 The announcement is

 

New announcement

 

1.5 Date of this announcement

 

30/1/2025

 

 

Appendix 2A - Application for quotation of securities

 

Part 2 - Type of Issue

 

 

2.1 The +securities to be quoted are:

 

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

 

2.2 The +class of +securities to be quoted is:

 

Additional +securities in a class that is already quoted on ASX (“existing class”)

 

 

Appendix 2A - Application for quotation of securities

 

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

 

 

Existing +securities converting into additional +securities in an existing class

 

FROM (Existing Class)

 

ASX +security code and description

 

ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004

 

TO (Existing Class)

 

ASX +security code and description

 

ATH : ORDINARY FULLY PAID

 

	Please state the number of options that were exercised or other +convertible securities that were converted		The first date the options were exercised or other +convertible securities were converted		The last date the options were exercised or other +convertible securities were converted
	6,333,333				30/1/2025

 

Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)?

 

No

 

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:

 

An issue of new +securities

 

The underlying +securities being received by the holder are:

 

Intended to be, but are not yet, quoted by ASX

 

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?

 

Yes

 

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate?

 

No

 

Issue date

 

30/1/2025

 

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?

 

Yes 

 

 

Appendix 2A - Application for quotation of securities

 

Issue details

 

 

Number of +securities to be quoted

 

6,333,333

 

Are the +securities being issued for a cash consideration?

 

Yes

 

In what currency is the cash consideration being paid?

What is the issue price per +security?

 

AUD - Australian Dollar

AUD 0.00400000

 

Any other information the entity wishes to provide about the +securities to be quoted

 

 

 

Appendix 2A - Application for quotation of securities

 

Part 4 - Issued capital following quotation

 

 

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

 

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity’s current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

 

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

 

ASX +security code and description		Total number of +securities on issue
ATH : ORDINARY FULLY PAID			5,326,764,689
ATHO : OPTION EXPIRING 31-AUG-2026			932,611,430

 

4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX)

 

ASX +security code and description		Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375			14,250,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238			11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09			35,000,000
ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01			170,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105			8,000,000
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031			62,500,000
ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004			20,166,667
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003			120,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032			91,392,720

 

 

---